Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0023-2025

Drug recall · October 30, 2024

Thiamine HCl 0.9% Sodium Chloride Injection USP recall

Why: cGMP violations

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56

Lots / codes

Lot # C274-000037436, exp. date 30-Oct-24 C274-000038893, exp. date 7-Jan-25

Quantity
1008 bags
Company
Fresenius Kabi Compounding, LLC, Canton, MA
Distribution
Product was distributed to 125 direct accounts nationwide.
Initiated
September 25, 2024 · Voluntary: Firm initiated
Classified
October 21, 2024
Reported
October 30, 2024
Ended
August 15, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Thiamine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.